Average Co-Inventor Count = 6.39
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (19 from 3,923 patents)
19 patents:
1. 9676728 - 2-benzyl-benzimidazole complement factor B inhibitors and uses thereof
2. 9603819 - Substituted aminobutyric derivatives as neprilysin inhibitors
3. 9505755 - Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5A receptor modulators
4. 9475806 - Complement factor B inhibitors and uses there of
5. 9056874 - Complement pathway modulators and uses thereof
6. 9006249 - Substituted aminobutyric derivatives as neprilysin inhibitors
7. 8877815 - Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
8. 8877786 - Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
9. 8846656 - Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators
10. 8759365 - Organic compounds
11. 8673974 - Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
12. 8642635 - Substituted carbamoylmethylamino acetic acid derivatives as novel NEP inhibitors
13. 8440682 - 4-benzylamino-1-carboxylacyl-piperidine derivatives as CETP inhibitors
14. 8420641 - Method of inhibiting CETP activity with 4-benzylamino-1-carboxylacyl-piperidine derivatives
15. 8394853 - Substituted aminopropionic derivatives as neprilysin inhibitors